Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

Breakthrough discovery in cancer research! Scientists uncover a simple genetic strategy to combat aggressive cancers. Learn ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt ...

the United States’ Array BioPharma and Targacept Ltd and Danish 7TM Pharma. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company ...

The sensor consists of an array of microscopic plastic needles mounted on a flexible base. That base is coated with a chitosan-based hydrogel capable of detecting small amounts of hydrogen ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

CRISPR technologies, epigenetics and data analytics software. AGD began sequencing to develop its clinical genomic database in January 2023, making it one of the fastest large-scale genomics ...

We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025.

This article explores 6-base genome sequencing and how it is empowering researchers to expand their studies to include both ...